A Successful Conclusion | Hemos Shines at CBE 2026, with Recombinant Humanized Keratin Pioneering a New Trend in the Beauty Industry
Category: Company News
Release time: 2026-06-01
Overview: From May 12–14, Hemos Bioscience showcased recombinant human keratin at the 30th CBE China Beauty Expo as "Barrier Repair Expert & Hair Strengthening Master." Its solutions for hair, skin, and oral care, backed by a full-service model (raw materials, OEM/ODM, custom development), drew strong client interest. The company won the "Industry-Academia-Research Excellence Case" award and was shortlisted for the "CBE China Raw Material Award." Hemos will continue to expand keratin applications and partnerships to drive sustainable, professional growth in the beauty industry.

From May 12 to 14, 2026, the 30th CBE China Beauty Expo successfully concluded at the Shanghai New International Expo Center. As a premier industry “trendsetter” event, this year’s expo was themed “Thirty Years of Innovation, Rising with the Tide,” bringing together over 3,200 companies from more than 40 countries and regions worldwide. It showcased over 80,000 products, including new releases and cutting-edge technological advancements, while fostering an innovative ecosystem that spans the entire beauty industry value chain.
Hemos Bioscience

During the exhibition, Hemos’ booth remained highly popular, with a steady stream of inquiries and discussions.
Hemos made a grand appearance with cutting-edge synthetic biology research findings, core functional ingredients, and multi-scenario application solutions, with a product portfolio spanning the three core areas of hair care, skincare, and oral care. Relying on “ Raw Material Supply + OEM/ODM + Custom Development A three-in-one end-to-end service system that streamlines the rapid translation of research and development into market implementation, precisely aligning with partners’ needs.

The on-site professional team through Technical explanation + efficacy demonstration + case studies In a multidimensional format, it comprehensively showcases the core advantages and application value of Recombinant Keratin, with the momentum of collaborative negotiations continuing to rise.


Leveraging its independent R&D and industrialization capabilities in the field of Recombinant Keratin, Hemos Bioscience has successfully obtained “ 2026 China Cosmetics Industry–Academia–Research Outstanding Case – Innovation Achievement Award “And also shortlisted” 2026 CBE China Raw Materials Award “The core raw materials were showcased collectively at the exhibition’s dedicated session.”


This award and nomination represent not only the industry’s full recognition of Hemos’ synthetic biology technology platform, but also an authoritative endorsement of the efficacy, technological approach, and industrialization prospects of Recombinant Keratin.
Hemos Bioscience sincerely thanks every partner and industry colleague who visited our booth for their trust and support.

In the future, Hemos Bioscience will continue to deepen its expertise in the field of Recombinant Keratin, iteratively upgrade its core synthetic biology technologies, and steadily expand the boundaries of its applications across skincare, hair care, and oral care. It will also continuously refine its end-to-end service system, leveraging scientific research and innovation to drive the beauty industry toward greater professionalism, ecological sustainability, and long-term viability.
Hemos Bioscience looks forward to joining hands with more partners to provide global consumers with safer, more efficient, and more precise beauty and personal care ingredient solutions, jointly reaching new heights in the beauty industry.
Keywords: A Successful Conclusion | Hemos Shines at CBE 2026, with Recombinant Humanized Keratin Pioneering a New Trend in the Beauty Industry
Relevant Information
Company News
-
New Starting Point, New Journey | Hemos Bioscience R&D Center Officially Moves into the Chongqing Biomanufacturing Industry Pilot-Scale Platform
Time:2026-08-04
-
New Regulation Interpretation | With the new regulations on cosmetic ingredients now in effect, Recombinant Keratin is entering a golden period of accelerated industrialization.
Time:2026-07-27
-
A delegation from Chongqing Yufu Holding Group and Chongqing Machinery & Electrical Group paid a visit to Hemos Bioscience for inspection and exchange.
Time:2026-07-14
-
Hemos has joined Chongqing’s biomanufacturing pilot platform, accelerating the industrialization of Recombinant Keratin across the board.
Time:2026-06-24
-
Recombinant Humanized Keratin: Hair care is advancing from “surface modification” to “structural repair”
Time:2026-06-18
-
Hemos Bio was invited to attend the 6th SynBio China Conference on Synthetic Biology and Biomanufacturing, where General Manager Huang Gang delivered a keynote speech.
Time:2026-06-01
-
A Successful Conclusion | Hemos Shines at CBE 2026, with Recombinant Humanized Keratin Pioneering a New Trend in the Beauty Industry
Time:2026-06-01
-
Invitation | Hemos Bio Invites You to the 2026 CBE Beauty Industry Gala
Time:2026-05-06
-
PCHi2026 Concludes Successfully | Hemos Leads the Beauty and Personal Care Ingredients Sector with Recombinant Humanized Keratin
Time:2026-03-30
-
Great News! Hemos has been awarded the 2025 China Bio-Manufacturing "Phoenix Award—Annual Industrialization Pioneer Award."
Time:2025-12-17
-
Equipment Upgrade·Capacity Surge|Hemos Bioscience Accelerates High-Quality Development
Time:2025-12-17
-
New Cooperation, New Chapter | Hemos and Southwest University of Science and Technology Officially Inaugurate the “Industry-University-Research Practice Base”
Time:2025-12-17
-
Hemos Bioscience and Geliya have established a strategic partnership, leveraging biotechnology to empower the beauty economy.
Time:2025-12-17
-
Milestone Collaboration! Hemos Bio × Leng Suan Ling: Launching a New Pathway for Anti-Sensitivity and Repair
Time:2025-12-17
-
Innovative Breakthrough! Hemos Bioscience Granted Two More National Invention Patents
Time:2025-12-17
Industry News
-
A new era of recombinant keratin is about to begin—this research team from Chongqing University is leading the world.
Time:2025-12-17
-
After more than a decade of dedicated research by a team of scientists and a pilot-scale production base with an annual capacity of tons, Hemos Biotech is committed to becoming a global leader in the recombinant keratin industry.
Time:2025-12-17
-
Major breakthrough: Chongqing develops effective recombinant keratin.
Time:2025-12-17